Lv6
1726 积分 2025-03-16 加入
Distinct molecular pathways regulated by activated AKT and YAP signaling during intrahepatic cholangiocarcinoma progression
1个月前
已完结
Safety and Effectiveness of Glucagon-like Peptide-1 Receptor Agonists in Inflammatory Bowel Disease
2个月前
已完结
Glucagon-Like Peptide-1 Receptor Agonists and Gastrointestinal Adverse Events: A Systematic Review and Meta-Analysis
2个月前
已完结
Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases
2个月前
已完结
GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
2个月前
已完结
Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort study
2个月前
已完结
Impaired incretin homeostasis in non-diabetic moderate to severe chronic kidney disease
3个月前
已完结
Endothelial dysfunction, endothelial nitric oxide bioavailability, tetrahydrobiopterin, and 5-methyltetrahydrofolate in cardiovascular disease. Where are we with therapy?
3个月前
已完结
Metabolomics study reveals systematic metabolic dysregulation and early detection markers associated with incident pancreatic cancer
4个月前
已完结
Acute-on-chronic liver failure: pathophysiological mechanisms and clinical management
4个月前
已关闭
皖公网安备34019202002308
